ID   DOPO_HUMAN              Reviewed;         617 AA.
AC   P09172; Q5T381; Q96AG2;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   24-JUL-2007, sequence version 3.
DT   10-MAY-2017, entry version 188.
DE   RecName: Full=Dopamine beta-hydroxylase;
DE            EC=1.14.17.1 {ECO:0000269|PubMed:3443096, ECO:0000269|PubMed:7961964, ECO:0000269|PubMed:8546710};
DE   AltName: Full=Dopamine beta-monooxygenase;
DE   Contains:
DE     RecName: Full=Soluble dopamine beta-hydroxylase;
GN   Name=DBH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 2-617, PARTIAL PROTEIN SEQUENCE,
RP   VARIANTS THR-211 AND CYS-549, CATALYTIC ACTIVITY, FUNCTION, AND
RP   PATHWAY.
RX   PubMed=3443096;
RA   Lamouroux A., Vigny A., Faucon Biguet N., Darmon M.C., Franck R.,
RA   Henry J.-P., Mallet J.;
RT   "The primary structure of human dopamine-beta-hydroxylase: insights
RT   into the relationship between the soluble and the membrane-bound forms
RT   of the enzyme.";
RL   EMBO J. 6:3931-3937(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 3-617.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 5-617.
RX   PubMed=2922261; DOI=10.1093/nar/17.3.1089;
RA   Kobayashi K., Kurosawa Y., Fukita K., Nagatsu T.;
RT   "Human dopamine beta-hydroxylase gene: two mRNA types having different
RT   3'-terminal regions are produced through alternative
RT   polyadenylation.";
RL   Nucleic Acids Res. 17:1089-1102(1989).
RN   [5]
RP   PROTEIN SEQUENCE OF 40-48, CATALYTIC ACTIVITY, FUNCTION, PATHWAY,
RP   SUBCELLULAR LOCATION, GLYCOSYLATION, COFACTOR, AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RX   PubMed=8546710; DOI=10.1042/bj3130057;
RA   Li B., Tsing S., Kosaka A.H., Nguyen B., Osen E.G., Bach C., Chan H.,
RA   Barnett J.;
RT   "Expression of human dopamine beta-hydroxylase in Drosophila Schneider
RT   2 cells.";
RL   Biochem. J. 313:57-64(1996).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, AND SUBCELLULAR LOCATION.
RX   PubMed=7961964;
RA   Kobayashi K., Morita S., Mizuguchi T., Sawada H., Yamada K.,
RA   Nagatsu I., Fujita K., Nagatsu T.;
RT   "Functional and high level expression of human dopamine beta-
RT   hydroxylase in transgenic mice.";
RL   J. Biol. Chem. 269:29725-29731(1994).
RN   [7]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-184.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [8]
RP   GLYCOSYLATION AT ASN-184.
RX   PubMed=19139490; DOI=10.1074/mcp.M800504-MCP200;
RA   Jia W., Lu Z., Fu Y., Wang H.P., Wang L.H., Chi H., Yuan Z.F.,
RA   Zheng Z.B., Song L.N., Han H.H., Liang Y.M., Wang J.L., Cai Y.,
RA   Zhang Y.K., Deng Y.L., Ying W.T., He S.M., Qian X.H.;
RT   "A strategy for precise and large scale identification of core
RT   fucosylated glycoproteins.";
RL   Mol. Cell. Proteomics 8:913-923(2009).
RN   [9]
RP   FUNCTION, AND PATHWAY.
RX   PubMed=27148966; DOI=10.1371/journal.pone.0154864;
RA   Cubells J.F., Schroeder J.P., Barrie E.S., Manvich D.F., Sadee W.,
RA   Berg T., Mercer K., Stowe T.A., Liles L.C., Squires K.E., Mezher A.,
RA   Curtin P., Perdomo D.L., Szot P., Weinshenker D.;
RT   "Human bacterial artificial chromosome (BAC) transgenesis fully
RT   rescues noradrenergic function in dopamine beta-hydroxylase knockout
RT   mice.";
RL   PLoS ONE 11:E0154864-E0154864(2016).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.90 ANGSTROMS) OF 40-617 IN COMPLEX WITH
RP   COPPER IONS, SUBUNIT, DISULFIDE BONDS, GLYCOSYLATION AT ASN-64;
RP   ASN-184 AND ASN-566, AND COFACTOR.
RX   PubMed=27152332; DOI=10.1126/sciadv.1500980;
RA   Vendelboe T.V., Harris P., Zhao Y., Walter T.S., Harlos K.,
RA   El Omari K., Christensen H.E.;
RT   "The crystal structure of human dopamine beta-hydroxylase at 2.9 A
RT   resolution.";
RL   Sci. Adv. 2:E1500980-E1500980(2016).
RN   [11]
RP   VARIANT SER-318.
RX   PubMed=10490716;
RX   DOI=10.1002/(SICI)1096-8628(19991015)88:5<557::AID-AJMG22>3.0.CO;2-F;
RA   Williams H.J., Bray N., Murphy K.C., Cardno A.G., Jones L.A.,
RA   Owen M.J.;
RT   "No evidence for allelic association between schizophrenia and a
RT   functional variant of the human dopamine beta-hydroxylase gene
RT   (DBH).";
RL   Am. J. Med. Genet. 88:557-559(1999).
RN   [12]
RP   VARIANTS SER-318 AND CYS-549.
RX   PubMed=10391209; DOI=10.1038/10290;
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RT   "Characterization of single-nucleotide polymorphisms in coding regions
RT   of human genes.";
RL   Nat. Genet. 22:231-238(1999).
RN   [13]
RP   ERRATUM.
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RL   Nat. Genet. 23:373-373(1999).
RN   [14]
RP   VARIANTS THR-211 AND SER-318.
RX   PubMed=10391210; DOI=10.1038/10297;
RA   Halushka M.K., Fan J.-B., Bentley K., Hsie L., Shen N., Weder A.,
RA   Cooper R., Lipshutz R., Chakravarti A.;
RT   "Patterns of single-nucleotide polymorphisms in candidate genes for
RT   blood-pressure homeostasis.";
RL   Nat. Genet. 22:239-247(1999).
RN   [15]
RP   VARIANTS DBH DEFICIENCY MET-101; GLU-114 AND ASN-345.
RX   PubMed=11857564; DOI=10.1002/ajmg.10196.abs;
RA   Kim C.-H., Zabetian C.P., Cubells J.F., Cho S., Biaggioni I.,
RA   Cohen B.M., Robertson D., Kim K.-S.;
RT   "Mutations in the dopamine beta-hydroxylase gene are associated with
RT   human norepinephrine deficiency.";
RL   Am. J. Med. Genet. 108:140-147(2002).
CC   -!- FUNCTION: Conversion of dopamine to noradrenaline.
CC       {ECO:0000269|PubMed:27148966, ECO:0000269|PubMed:3443096,
CC       ECO:0000269|PubMed:7961964, ECO:0000269|PubMed:8546710}.
CC   -!- CATALYTIC ACTIVITY: 3,4-dihydroxyphenethylamine + ascorbate + O(2)
CC       = noradrenaline + dehydroascorbate + H(2)O.
CC       {ECO:0000269|PubMed:3443096, ECO:0000269|PubMed:7961964,
CC       ECO:0000269|PubMed:8546710}.
CC   -!- COFACTOR:
CC       Name=Cu(2+); Xref=ChEBI:CHEBI:29036;
CC         Evidence={ECO:0000269|PubMed:8546710,
CC         ECO:0000305|PubMed:27152332};
CC       Note=Binds 2 copper ions per subunit.
CC       {ECO:0000305|PubMed:27152332};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.8 mM for tyramine {ECO:0000269|PubMed:8546710};
CC       pH dependence:
CC         Optimum pH is 5.2. {ECO:0000269|PubMed:8546710};
CC   -!- PATHWAY: Catecholamine biosynthesis; (R)-noradrenaline
CC       biosynthesis; (R)-noradrenaline from dopamine: step 1/1.
CC       {ECO:0000269|PubMed:27148966, ECO:0000269|PubMed:3443096,
CC       ECO:0000269|PubMed:8546710}.
CC   -!- SUBUNIT: Homotetramer; composed of two disulfide-linked dimers.
CC       {ECO:0000269|PubMed:27152332}.
CC   -!- SUBCELLULAR LOCATION: Soluble dopamine beta-hydroxylase:
CC       Cytoplasmic vesicle, secretory vesicle lumen
CC       {ECO:0000269|PubMed:7961964}. Cytoplasmic vesicle, secretory
CC       vesicle, chromaffin granule lumen {ECO:0000269|PubMed:7961964}.
CC       Secreted {ECO:0000269|PubMed:7961964, ECO:0000269|PubMed:8546710}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle
CC       membrane {ECO:0000269|PubMed:7961964}; Single-pass type II
CC       membrane protein {ECO:0000305}. Cytoplasmic vesicle, secretory
CC       vesicle, chromaffin granule membrane {ECO:0000269|PubMed:7961964};
CC       Single-pass type II membrane protein {ECO:0000305}.
CC   -!- INDUCTION: Activity is enhanced by nerve growth factor (in
CC       superior cervical ganglia and adrenal medulla). Trans-synaptic
CC       stimulation with reserpine, acetylcholine and glucocorticoids.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:27152332,
CC       ECO:0000269|PubMed:8546710}.
CC   -!- PTM: Proteolytic cleavage after the membrane-anchor leads to the
CC       release of the soluble form. {ECO:0000250|UniProtKB:P15101}.
CC   -!- POLYMORPHISM: There are two main alleles of DBH: DBH-A with Ala-
CC       318 and DBH-B with Ser-318 (PubMed:10490716, PubMed:10391209,
CC       PubMed:10391210). {ECO:0000269|PubMed:10391209,
CC       ECO:0000269|PubMed:10391210, ECO:0000269|PubMed:10490716}.
CC   -!- DISEASE: Dopamine beta-hydroxylase deficiency (DBH deficiency)
CC       [MIM:223360]: Characterized by profound deficits in autonomic and
CC       cardiovascular function, but apparently only subtle signs, if any,
CC       of central nervous system dysfunction.
CC       {ECO:0000269|PubMed:11857564}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the copper type II ascorbate-dependent
CC       monooxygenase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH17174.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=CAA31631.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=CAA31632.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=CAA68285.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Dopamine beta hydroxylase
CC       entry;
CC       URL="https://en.wikipedia.org/wiki/Dopamine_beta_hydroxylase";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL365494; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Y00096; CAA68285.1; ALT_INIT; mRNA.
DR   EMBL; BC017174; AAH17174.1; ALT_INIT; mRNA.
DR   EMBL; X13255; CAA31631.1; ALT_INIT; mRNA.
DR   EMBL; X13256; CAA31632.1; ALT_INIT; mRNA.
DR   CCDS; CCDS6977.2; -.
DR   PIR; S03020; S03020.
DR   RefSeq; NP_000778.3; NM_000787.3.
DR   UniGene; Hs.591890; -.
DR   PDB; 4ZEL; X-ray; 2.90 A; A/B=40-617.
DR   PDBsum; 4ZEL; -.
DR   ProteinModelPortal; P09172; -.
DR   SMR; P09172; -.
DR   BioGrid; 107989; 4.
DR   IntAct; P09172; 2.
DR   MINT; MINT-2843963; -.
DR   STRING; 9606.ENSP00000376776; -.
DR   BindingDB; P09172; -.
DR   ChEMBL; CHEMBL3102; -.
DR   DrugBank; DB06774; Capsaicin.
DR   DrugBank; DB05394; corticotropin-releasing factor.
DR   DrugBank; DB00822; Disulfiram.
DR   DrugBank; DB00988; Dopamine.
DR   DrugBank; DB00550; Propylthiouracil.
DR   DrugBank; DB00126; Vitamin C.
DR   GuidetoPHARMACOLOGY; 2486; -.
DR   iPTMnet; P09172; -.
DR   PhosphoSitePlus; P09172; -.
DR   BioMuta; DBH; -.
DR   DMDM; 158517849; -.
DR   PaxDb; P09172; -.
DR   PeptideAtlas; P09172; -.
DR   PRIDE; P09172; -.
DR   DNASU; 1621; -.
DR   Ensembl; ENST00000393056; ENSP00000376776; ENSG00000123454.
DR   GeneID; 1621; -.
DR   KEGG; hsa:1621; -.
DR   UCSC; uc004cel.4; human.
DR   CTD; 1621; -.
DR   DisGeNET; 1621; -.
DR   GeneCards; DBH; -.
DR   GeneReviews; DBH; -.
DR   H-InvDB; HIX0008510; -.
DR   HGNC; HGNC:2689; DBH.
DR   HPA; HPA002130; -.
DR   HPA; HPA005960; -.
DR   HPA; HPA070789; -.
DR   MalaCards; DBH; -.
DR   MIM; 223360; phenotype.
DR   MIM; 609312; gene.
DR   neXtProt; NX_P09172; -.
DR   OpenTargets; ENSG00000123454; -.
DR   Orphanet; 230; Dopamine beta-hydroxylase deficiency.
DR   PharmGKB; PA136; -.
DR   eggNOG; KOG3568; Eukaryota.
DR   eggNOG; ENOG410XR89; LUCA.
DR   GeneTree; ENSGT00530000063085; -.
DR   HOGENOM; HOG000063669; -.
DR   HOVERGEN; HBG005519; -.
DR   InParanoid; P09172; -.
DR   KO; K00503; -.
DR   OMA; SYFGDAW; -.
DR   OrthoDB; EOG091G03XS; -.
DR   PhylomeDB; P09172; -.
DR   TreeFam; TF320698; -.
DR   BioCyc; MetaCyc:MONOMER66-381; -.
DR   BRENDA; 1.14.17.1; 2681.
DR   Reactome; R-HSA-209905; Catecholamine biosynthesis.
DR   SignaLink; P09172; -.
DR   SIGNOR; P09172; -.
DR   UniPathway; UPA00748; UER00735.
DR   GeneWiki; Dopamine_beta_hydroxylase; -.
DR   GenomeRNAi; 1621; -.
DR   PRO; PR:P09172; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000123454; -.
DR   CleanEx; HS_DBH; -.
DR   ExpressionAtlas; P09172; baseline and differential.
DR   Genevisible; P09172; HS.
DR   GO; GO:0034466; C:chromaffin granule lumen; IEA:UniProtKB-SubCell.
DR   GO; GO:0042584; C:chromaffin granule membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005576; C:extracellular region; NAS:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0034774; C:secretory granule lumen; IDA:UniProtKB.
DR   GO; GO:0030667; C:secretory granule membrane; IDA:UniProtKB.
DR   GO; GO:0030658; C:transport vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0003824; F:catalytic activity; TAS:ProtInc.
DR   GO; GO:0005507; F:copper ion binding; IDA:UniProtKB.
DR   GO; GO:0004500; F:dopamine beta-monooxygenase activity; IDA:UniProtKB.
DR   GO; GO:0031418; F:L-ascorbic acid binding; IEA:UniProtKB-KW.
DR   GO; GO:0048149; P:behavioral response to ethanol; IEA:Ensembl.
DR   GO; GO:0001974; P:blood vessel remodeling; IEA:Ensembl.
DR   GO; GO:0042423; P:catecholamine biosynthetic process; TAS:Reactome.
DR   GO; GO:0007268; P:chemical synaptic transmission; TAS:ProtInc.
DR   GO; GO:0001816; P:cytokine production; IEA:Ensembl.
DR   GO; GO:0042420; P:dopamine catabolic process; IDA:UniProtKB.
DR   GO; GO:0042596; P:fear response; IEA:Ensembl.
DR   GO; GO:0042593; P:glucose homeostasis; IEA:Ensembl.
DR   GO; GO:0042309; P:homoiothermy; IEA:Ensembl.
DR   GO; GO:0002443; P:leukocyte mediated immunity; IEA:Ensembl.
DR   GO; GO:0050900; P:leukocyte migration; IEA:Ensembl.
DR   GO; GO:0007626; P:locomotory behavior; IEA:Ensembl.
DR   GO; GO:0042711; P:maternal behavior; IEA:Ensembl.
DR   GO; GO:0007613; P:memory; IEA:Ensembl.
DR   GO; GO:0042421; P:norepinephrine biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0006589; P:octopamine biosynthetic process; IBA:GO_Central.
DR   GO; GO:0045907; P:positive regulation of vasoconstriction; IEA:Ensembl.
DR   GO; GO:0042127; P:regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:2001236; P:regulation of extrinsic apoptotic signaling pathway; IEA:Ensembl.
DR   GO; GO:0001975; P:response to amphetamine; IEA:Ensembl.
DR   GO; GO:0048265; P:response to pain; IEA:Ensembl.
DR   GO; GO:0008542; P:visual learning; IEA:Ensembl.
DR   Gene3D; 2.60.120.230; -; 1.
DR   Gene3D; 2.60.120.310; -; 1.
DR   InterPro; IPR014784; Cu2_ascorb_mOase-like_C.
DR   InterPro; IPR020611; Cu2_ascorb_mOase_CS-1.
DR   InterPro; IPR014783; Cu2_ascorb_mOase_CS-2.
DR   InterPro; IPR000323; Cu2_ascorb_mOase_N.
DR   InterPro; IPR024548; Cu2_monoox_C.
DR   InterPro; IPR000945; DBH-rel.
DR   InterPro; IPR005018; DOMON_domain.
DR   InterPro; IPR008977; PHM/PNGase_F_dom.
DR   InterPro; IPR028460; Tbh/DBH.
DR   PANTHER; PTHR10157:SF31; PTHR10157:SF31; 1.
DR   Pfam; PF03712; Cu2_monoox_C; 1.
DR   Pfam; PF01082; Cu2_monooxygen; 1.
DR   Pfam; PF03351; DOMON; 1.
DR   PRINTS; PR00767; DBMONOXGNASE.
DR   SMART; SM00664; DoH; 1.
DR   SUPFAM; SSF49742; SSF49742; 2.
DR   PROSITE; PS00084; CU2_MONOOXYGENASE_1; 1.
DR   PROSITE; PS00085; CU2_MONOOXYGENASE_2; 1.
DR   PROSITE; PS50836; DOMON; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Catecholamine biosynthesis; Complete proteome; Copper;
KW   Cytoplasmic vesicle; Direct protein sequencing; Disease mutation;
KW   Disulfide bond; Glycoprotein; Membrane; Metal-binding; Monooxygenase;
KW   Oxidoreductase; Polymorphism; Reference proteome; Secreted;
KW   Signal-anchor; Transmembrane; Transmembrane helix; Vitamin C.
FT   CHAIN         1    617       Dopamine beta-hydroxylase.
FT                                /FTId=PRO_0000006356.
FT   CHAIN        40    617       Soluble dopamine beta-hydroxylase.
FT                                /FTId=PRO_0000308209.
FT   TOPO_DOM      1     16       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     17     37       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     38    617       Intragranular. {ECO:0000255}.
FT   DOMAIN       57    173       DOMON. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00246}.
FT   ACT_SITE    230    230       {ECO:0000255}.
FT   ACT_SITE    412    412       {ECO:0000255}.
FT   METAL       262    262       Copper A. {ECO:0000250}.
FT   METAL       263    263       Copper A. {ECO:0000250}.
FT   METAL       333    333       Copper A. {ECO:0000250}.
FT   METAL       412    412       Copper B. {ECO:0000244|PDB:4ZEL,
FT                                ECO:0000305|PubMed:27152332}.
FT   METAL       414    414       Copper B. {ECO:0000244|PDB:4ZEL,
FT                                ECO:0000305|PubMed:27152332}.
FT   METAL       487    487       Copper B. {ECO:0000244|PDB:4ZEL,
FT                                ECO:0000305|PubMed:27152332}.
FT   SITE         39     40       Cleavage. {ECO:0000250|UniProtKB:P15101}.
FT   CARBOHYD     64     64       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:4ZEL, ECO:0000255,
FT                                ECO:0000269|PubMed:27152332}.
FT   CARBOHYD    184    184       N-linked (GlcNAc...) (complex)
FT                                asparagine. {ECO:0000244|PDB:4ZEL,
FT                                ECO:0000269|PubMed:16335952,
FT                                ECO:0000269|PubMed:19139490,
FT                                ECO:0000269|PubMed:27152332}.
FT   CARBOHYD    566    566       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:4ZEL,
FT                                ECO:0000269|PubMed:27152332}.
FT   DISULFID    154    596       {ECO:0000244|PDB:4ZEL,
FT                                ECO:0000269|PubMed:27152332}.
FT   DISULFID    232    283       {ECO:0000244|PDB:4ZEL,
FT                                ECO:0000269|PubMed:27152332}.
FT   DISULFID    269    295       {ECO:0000244|PDB:4ZEL,
FT                                ECO:0000269|PubMed:27152332}.
FT   DISULFID    390    503       {ECO:0000244|PDB:4ZEL,
FT                                ECO:0000269|PubMed:27152332}.
FT   DISULFID    394    565       {ECO:0000244|PDB:4ZEL,
FT                                ECO:0000269|PubMed:27152332}.
FT   DISULFID    466    488       {ECO:0000244|PDB:4ZEL,
FT                                ECO:0000269|PubMed:27152332}.
FT   DISULFID    528    528       Interchain (with C-530).
FT                                {ECO:0000244|PDB:4ZEL,
FT                                ECO:0000269|PubMed:27152332}.
FT   DISULFID    530    530       Interchain (with C-528).
FT                                {ECO:0000244|PDB:4ZEL,
FT                                ECO:0000269|PubMed:27152332}.
FT   VARIANT      12     12       G -> S (in dbSNP:rs5318).
FT                                /FTId=VAR_048838.
FT   VARIANT     101    101       V -> M (in DBH deficiency;
FT                                dbSNP:rs267606760).
FT                                {ECO:0000269|PubMed:11857564}.
FT                                /FTId=VAR_022758.
FT   VARIANT     114    114       D -> E (in DBH deficiency;
FT                                dbSNP:rs77576840).
FT                                {ECO:0000269|PubMed:11857564}.
FT                                /FTId=VAR_022759.
FT   VARIANT     181    181       E -> Q (in dbSNP:rs5319).
FT                                /FTId=VAR_014706.
FT   VARIANT     211    211       A -> T (in dbSNP:rs5320).
FT                                {ECO:0000269|PubMed:10391210,
FT                                ECO:0000269|PubMed:3443096}.
FT                                /FTId=VAR_013947.
FT   VARIANT     239    239       K -> N (in dbSNP:rs5321).
FT                                /FTId=VAR_014707.
FT   VARIANT     250    250       E -> Q (in dbSNP:rs5323).
FT                                /FTId=VAR_014708.
FT   VARIANT     290    290       D -> N (in dbSNP:rs5324).
FT                                /FTId=VAR_014709.
FT   VARIANT     317    317       L -> P (in dbSNP:rs5325).
FT                                /FTId=VAR_014710.
FT   VARIANT     318    318       A -> S (in allele DBH-B; dbSNP:rs4531).
FT                                {ECO:0000269|PubMed:10391209,
FT                                ECO:0000269|PubMed:10391210,
FT                                ECO:0000269|PubMed:10490716}.
FT                                /FTId=VAR_002196.
FT   VARIANT     345    345       D -> N (in DBH deficiency;
FT                                dbSNP:rs267606761).
FT                                {ECO:0000269|PubMed:11857564}.
FT                                /FTId=VAR_022760.
FT   VARIANT     549    549       R -> C (in dbSNP:rs6271).
FT                                {ECO:0000269|PubMed:10391209,
FT                                ECO:0000269|PubMed:3443096}.
FT                                /FTId=VAR_013948.
FT   CONFLICT    505    505       S -> T (in Ref. 2; CAA68285 and 4;
FT                                CAA31631/CAA31632). {ECO:0000305}.
FT   STRAND       48     52       {ECO:0000244|PDB:4ZEL}.
FT   STRAND       58     66       {ECO:0000244|PDB:4ZEL}.
FT   TURN         67     70       {ECO:0000244|PDB:4ZEL}.
FT   STRAND       71     80       {ECO:0000244|PDB:4ZEL}.
FT   STRAND       83     93       {ECO:0000244|PDB:4ZEL}.
FT   STRAND       98    104       {ECO:0000244|PDB:4ZEL}.
FT   STRAND      111    117       {ECO:0000244|PDB:4ZEL}.
FT   STRAND      123    125       {ECO:0000244|PDB:4ZEL}.
FT   STRAND      130    138       {ECO:0000244|PDB:4ZEL}.
FT   STRAND      143    151       {ECO:0000244|PDB:4ZEL}.
FT   STRAND      166    173       {ECO:0000244|PDB:4ZEL}.
FT   STRAND      191    195       {ECO:0000244|PDB:4ZEL}.
FT   STRAND      212    217       {ECO:0000244|PDB:4ZEL}.
FT   STRAND      220    222       {ECO:0000244|PDB:4ZEL}.
FT   STRAND      225    236       {ECO:0000244|PDB:4ZEL}.
FT   STRAND      244    252       {ECO:0000244|PDB:4ZEL}.
FT   TURN        255    260       {ECO:0000244|PDB:4ZEL}.
FT   STRAND      261    268       {ECO:0000244|PDB:4ZEL}.
FT   STRAND      279    284       {ECO:0000244|PDB:4ZEL}.
FT   STRAND      286    288       {ECO:0000244|PDB:4ZEL}.
FT   STRAND      290    294       {ECO:0000244|PDB:4ZEL}.
FT   STRAND      297    303       {ECO:0000244|PDB:4ZEL}.
FT   STRAND      313    319       {ECO:0000244|PDB:4ZEL}.
FT   STRAND      327    335       {ECO:0000244|PDB:4ZEL}.
FT   STRAND      348    356       {ECO:0000244|PDB:4ZEL}.
FT   STRAND      359    361       {ECO:0000244|PDB:4ZEL}.
FT   STRAND      363    369       {ECO:0000244|PDB:4ZEL}.
FT   STRAND      375    377       {ECO:0000244|PDB:4ZEL}.
FT   STRAND      382    390       {ECO:0000244|PDB:4ZEL}.
FT   HELIX       392    398       {ECO:0000244|PDB:4ZEL}.
FT   STRAND      404    412       {ECO:0000244|PDB:4ZEL}.
FT   STRAND      417    426       {ECO:0000244|PDB:4ZEL}.
FT   STRAND      429    439       {ECO:0000244|PDB:4ZEL}.
FT   STRAND      448    456       {ECO:0000244|PDB:4ZEL}.
FT   STRAND      461    468       {ECO:0000244|PDB:4ZEL}.
FT   STRAND      477    482       {ECO:0000244|PDB:4ZEL}.
FT   STRAND      489    496       {ECO:0000244|PDB:4ZEL}.
FT   STRAND      499    507       {ECO:0000244|PDB:4ZEL}.
FT   HELIX       509    522       {ECO:0000244|PDB:4ZEL}.
FT   HELIX       535    539       {ECO:0000244|PDB:4ZEL}.
FT   HELIX       546    558       {ECO:0000244|PDB:4ZEL}.
FT   STRAND      561    567       {ECO:0000244|PDB:4ZEL}.
SQ   SEQUENCE   617 AA;  69065 MW;  4D5586F0E358885D CRC64;
     MPALSRWASL PGPSMREAAF MYSTAVAIFL VILVAALQGS APRESPLPYH IPLDPEGSLE
     LSWNVSYTQE AIHFQLLVRR LKAGVLFGMS DRGELENADL VVLWTDGDTA YFADAWSDQK
     GQIHLDPQQD YQLLQVQRTP EGLTLLFKRP FGTCDPKDYL IEDGTVHLVY GILEEPFRSL
     EAINGSGLQM GLQRVQLLKP NIPEPELPSD ACTMEVQAPN IQIPSQETTY WCYIKELPKG
     FSRHHIIKYE PIVTKGNEAL VHHMEVFQCA PEMDSVPHFS GPCDSKMKPD RLNYCRHVLA
     AWALGAKAFY YPEEAGLAFG GPGSSRYLRL EVHYHNPLVI EGRNDSSGIR LYYTAKLRRF
     NAGIMELGLV YTPVMAIPPR ETAFILTGYC TDKCTQLALP PSGIHIFASQ LHTHLTGRKV
     VTVLVRDGRE WEIVNQDNHY SPHFQEIRML KKVVSVHPGD VLITSCTYNT EDRELATVGG
     FGILEEMCVN YVHYYPQTQL ELCKSAVDAG FLQKYFHLIN RFNNEDVCTC PQASVSQQFT
     SVPWNSFNRD VLKALYSFAP ISMHCNKSSA VRFQGEWNLQ PLPKVISTLE EPTPQCPTSQ
     GRSPAGPTVV SIGGGKG
//
